Palivizumab is administered via intramuscular injection. The typical dosing schedule involves monthly injections during the RSV season, which usually runs from November to March in the Northern Hemisphere. The exact duration and frequency of dosing may vary based on regional RSV activity and the specific needs of the infant.
